Arcutis Biotherapeutics, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ARQT for the last quarter is 49.57 M USD, and it's 266.47% higher compared to the previous quarter. The net income of Q1 24 is -35.38 M USD.